EUVIMEDEUVIMED entdecken
Crossref

Effect of Prophylactic Administration of Foscarnet for HHV‐6 Encephalitis in Adult Single Cord Blood Transplantation

Kotaro Suzuki, Junya Kanda, Tomoki Iemura, Yasuyuki Arai, Yutaka Shimazu, Toshio Kitawaki, Chisaki Mizumoto, Kouhei Yamashita, Akifumi Takaori-Kondo

Transplant Infectious Disease · 2026

DOI: 10.1111/tid.70147 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Infectious Disease, 2026. Verfasst von Kotaro Suzuki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Foscarnet, Herpesvirus 6, Human, Roseolovirus Infections, Antiviral Agents. Die Arbeit nennt 31 Literaturangaben. Gefördert von: JSPS KAKENHI, the Takeda Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

HHV‐6 encephalitis is a serious complication after allogeneic hematopoietic stem cell transplantation. Whether foscarnet prophylaxis improves outcomes after unrelated cord blood transplantation (UCBT), particularly under systemic steroid exposure, and the renal safety of foscarnet remain uncertain.

Methods

This retrospective cohort consisted of 156 adult patients who received single‐unit UCBT between 2005 and 2022. Foscarnet prophylaxis was defined as any use of foscarnet without encephalitis onset, including planned administration after transplantation, pre‐emptive administration after HHV‐6 DNAemia, or other indications. Primary endpoint was 60‐day incidence of HHV‐6 encephalitis, and secondary endpoints were overall survival and renal function up to 12 months.

Results

The 60‐day cumulative incidence of HHV‐6 encephalitis was 10.9%; 121/156 (77.6%) received prophylaxis. Incidence did not differ significantly by foscarnet exposure (9.9% vs. 14.3%; p = 0.418) and this was not significant in the multivariable analysis. A high cumulative dose of corticosteroid was associated with higher incidence (28.6% vs. 7.1%; p = 0.001). In patients with low corticosteroid exposure, the incidence of HHV‐6 encephalitis was significantly lower with foscarnet prophylaxis (4.3% vs. 14.7%; p = 0.040). Among patients who developed encephalitis, 1‐year overall survival appeared higher with prior foscarnet exposure than in those without prior exposure (72.2% vs. 20%); renal function up to 12 months was similar.

Conclusions

Foscarnet prophylaxis was not significantly associated with a reduced incidence of HHV‐6 encephalitis after UCBT, whereas high‐dose steroid exposure was a risk factor. Notably, a lower incidence of encephalitis with foscarnet prophylaxis was observed in the low‐dose steroid subgroup, although this finding requires confirmation in larger cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FoscarnetHerpesvirus 6, HumanRoseolovirus InfectionsAntiviral AgentsEncephalitis, ViralCord Blood Stem Cell TransplantationHumansFemaleMaleRetrospective StudiesAdultMiddle AgedIncidenceYoung AdultAged

Substanzen

FoscarnetAntiviral Agents

Autor:innen und Institutionen

  • Department of Hematology and Oncology, Kyoto University, Kyoto, Japan.
  • Department of Clinical Laboratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Förderung

  • JSPS KAKENHI
  • the Takeda Science Foundation

Zitieren

APA

Suzuki, K., Kanda, J., Iemura, T., Arai, Y., Shimazu, Y., Kitawaki, T., Mizumoto, C., Yamashita, K., & Takaori-Kondo, A. (2026). Effect of Prophylactic Administration of Foscarnet for HHV‐6 Encephalitis in Adult Single Cord Blood Transplantation. Transplant Infectious Disease. https://doi.org/10.1111/tid.70147

Vancouver

Suzuki K, Kanda J, Iemura T, Arai Y, Shimazu Y, Kitawaki T, et al. Effect of Prophylactic Administration of Foscarnet for HHV‐6 Encephalitis in Adult Single Cord Blood Transplantation. Transplant Infectious Disease. 2026. doi:10.1111/tid.70147

BibTeX
@article{Suzuki2026,
  author = {Suzuki, Kotaro and Kanda, Junya and Iemura, Tomoki and Arai, Yasuyuki and Shimazu, Yutaka and Kitawaki, Toshio and Mizumoto, Chisaki and Yamashita, Kouhei and Takaori-Kondo, Akifumi},
  title = {Effect of Prophylactic Administration of Foscarnet for HHV‐6 Encephalitis in Adult Single Cord Blood Transplantation},
  journal = {Transplant Infectious Disease},
  year = {2026},
  doi = {10.1111/tid.70147}
}
Kostenlos starten →